SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is gaining significant momentum as the community focuses on its pivotal role in real-world asset (RWA) tokenization and upcoming legislative developments like the Clarity Act. Investors are actively discussing the stock's potential for institutional adoption and its critical function as a decentralized data bridge, while keeping a close watch on its ability to sustain current price levels.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA CRYPTO token is trending as investors and community members express widespread frustration, actively labeling it a pump-and-dump scheme that has resulted in significant financial losses. Discourse is heavily centered on skepticism regarding the project's legitimacy and broader critiques of the Trump family's involvement in various crypto ventures.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently a focal point for investors as recent institutional backing and anticipation surrounding clinical trial data continue to drive high volatility and short-squeeze speculation. The community is actively debating the potential of soquelitinib as an oral therapy alternative to injectables, with sentiment split between optimism over long-term platform maturation and concerns regarding the company's cash burn and clinical trial timelines.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

The PEPE community is actively debating the coin's future amidst a split between those betting on a major trend reversal and those cautioning about a potential downturn. Traders are closely watching support levels and broader market sentiment, with many focused on whether the asset can regain momentum as part of a wider rotation into high-beta meme tokens.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd. - ADR

Teva Pharmaceutical is trending as investors digest the company's progress in its 'Pivot to Growth' strategy, with the stock recently hitting new 52-week highs amid institutional accumulation and positive analyst commentary. Community discussion remains focused on the company's transition from a generics-heavy model to a more diversified specialty pharmaceutical portfolio, alongside active debate regarding the sustainability of recent price momentum and potential resistance levels.

Freddie Mac engages in the provision of housing finance system solutions. It operates through the Single-Family and Multifamily segments. The Single-Family segment is involved in purchase, securitization, and guarantee of single-family loans, investments, and management of single-family mortgage credit risk and market risk. The Multifamily segment focuses on purchase, securitization, and guarantee of multifamily loans, investments, securities, and management of multifamily mortgage credit risk and market risk. The company was founded on July 24, 1970 and is headquartered in McLean, VA.

Federal Home Loan Mortgage Corp

Freddie Mac

Investors in Freddie Mac are closely monitoring signals from the Trump administration and key figures like Bill Pulte, who recently reaffirmed that an IPO remains a potential path forward pending presidential action. The community is actively debating the timing of a possible release from conservatorship, with many shareholders maintaining long-term positions while interpreting recent mortgage policy shifts as signs of progress.

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

Immuneering Corp

Immuneering Corp is capturing significant community attention as its lead candidate, atebimetinib, continues to show robust survival data in first-line pancreatic cancer, with investors closely watching for upcoming Phase 3 milestones and clinical presentations at ASCO. The broader conversation is currently centered on the stock's potential for a valuation re-rating compared to other oncology players, as bulls highlight the company's strong cash position and the promise of its deep cyclic inhibitor platform.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

The Bitwise XRP ETF is currently driving market conversation as investors weigh institutional adoption against ongoing price volatility and regulatory uncertainty. Community sentiment remains deeply polarized between long-term holders focusing on potential utility in cross-border payments and skeptics concerned about token dilution and lack of immediate momentum.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is generating significant market interest following the FDA approval of its drug Trutakna for IgA nephropathy, with the community actively debating the potential for a strategic buyout and the company's competitive standing against other major biotech players. Investors are closely tracking institutional accumulation, high short interest, and upcoming commercialization updates, leading to ongoing speculation about the stock's future valuation and upside potential.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing heightened community interest driven by active governance voting, speculation regarding potential exchange relistings, and ongoing token burn initiatives. Investors remain deeply divided, with many long-term supporters highlighting the potential for a supply-side squeeze while others caution against the project's historical volatility and substantial circulating supply.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IT Gartner Announces the Inaugural Gartner Enterprise Risk, Audit &amp; Compliance Conference 2026 in London 
 
https://marketwirenews.com/stock/it/news/gartner-announces-the-inaugural-gartner-enterprise-r-8803416819981070.html?utm_source=stocktwits

Analysts to Discuss How Leaders Can Harness AI and Data and Analytics, and Demonstrate Business Value in Today's Rapidly Evolving Risk.

Market Wire News

Gartner Announces the Inaugural Gartner Enterprise Risk,...

StockTwits Web

Gartner, Inc.

 Gartner Announces the Inaugural Gartner Enterprise Risk, Audit & Compliance Conference 2026 in London 
 
